InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.84
(
-0.35%
)
Bitcoin
64,218.09
(
0.34%
)
Post# of 1990
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

austinmediainc

Send PM Follow Ignore
Followers 14
Posts 1735
Boards Moderated 0
Alias Born 01/21/2014

austinmediainc

Re: H2R post# 181

Wednesday, 01/25/2017 2:41:22 PM

Wednesday, January 25, 2017 2:41:22 PM

Post# of 1990
He is an admitted short, and his information is false. They have many drugs and studies in the pipeline, the Phase 2 showed significant improvement over Sunitinib mono-therapy, and a CLDX Phase 3 for GBM was stopped early last year for futility even though it was safe. Go to the ARGS website and review the latest presentation and conference calls. Very open and detailed.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up